Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important? – Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1300-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 6, 2015-06 ,pp. : 613-630

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: fibre and FODMAPs in constipation and irritable bowel syndrome

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 383-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 856-866

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome

By DiBonaventura Marco   Sun Shawn X.   Bolge Susan C.   Wagner Jan-Samuel   Mody Reema  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2213-2222

Informa Healthcare

Access to resources Recommend Favorite